Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8687745 | NeuroImage: Clinical | 2018 | 7 Pages |
Abstract
Results are notably concordant with the well-established anatomical changes signaling the progression to dementia in Alzheimer's disease, despite the dense baseline pathology that developmentally accumulates in Down syndrome. This commonality supports the potential value of Down syndrome as a genetic model of Alzheimer's neurodegeneration and may serve to further support the view that Down syndrome patients are best candidates to benefit from treatment research in Alzheimer's disease.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Jesus Pujol, Raquel Fenoll, Núria Ribas-Vidal, Gerard MartÃnez-Vilavella, Laura Blanco-Hinojo, Javier GarcÃa-Alba, Joan Deus, Ramón Novell, Susanna Esteba-Castillo,